RecruitingPhase 3NCT06511765

Anesthetic Block of the Erector Muscles of the Lumbar Spine to Relieve Acute Lumbar Pain: Pilot Study


Sponsor

Elsan

Enrollment

40 participants

Start Date

Mar 24, 2026

Study Type

INTERVENTIONAL

Conditions

Summary

This study concerns the treatment of recent lumbago and aims to evaluate the efficacy of an anesthetic block of the erector spinae muscles combining ropivacaine and dexamethasone. This treatment is routinely used in several institutions in France, but has never been the subject of a randomized placebo-controlled study to assess its efficacy at D4 of treatment. The BLOCLOMB comparative, randomized, double-blind study aims to validate the efficacy, over the first 4 days, of anesthetic blocks of the erector spinae muscles, during recent lumbago, on the pain of muscular contractures.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a drug called Ropivacaine and dexamethasone injection solution and a drug called Sodium Chloride 0.9% Injection Solution for people with lumbago. The study is currently recruiting participants at 1 location.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGRopivacaine and dexamethasone injection solution

Injection of Ropivacaine and dexamethasone

DRUGSodium Chloride 0.9% Injection Solution

Injection of sodium chloride 0.9%


Locations(1)

Santé Atlantique ELSAN

Saint-Herblain, France

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06511765


Related Trials